News

Filter by:

Limit to items where the date of the news item:
Date range
Limit to items where the date of the news item:
Limit to news where the title matches:
Limit to news items tagged with one or more of:
Limit to news items where the audience is one or more of:

Dr. Vivek Goel is recognized in Canada and around the world as a leading public-health researcher, health-services evaluation expert, and champion for the use of research evidence in health policy making.

He also currently serves on the boards of the Vector Institute, TRIUMF, the Canadian Institute for Health Information, Canada Health Labs, and the Post Promise.

Researchers have taken an important step in the development of a microscope to precisely guide doctors during surgery to remove brain tumors

For the first time, a team led by engineers at the University of Waterloo used laser imaging technology to almost instantly identify cancerous tissue with accuracy comparable to laboratory tests that take up to two weeks.

That means the Photoacoustic Remote Sensing (PARS) imaging system could tell doctors where a tumor ends and healthy tissue begins so they know exactly where to cut.

Digital X-ray technology developed by a University of Waterloo spinoff company has won approval from Health Canada.

A medical device licence issued for Reveal 35C, a dual-energy X-ray detector created by KA Imaging, follows clearance from the Food and Drug Administration in the United States earlier this month.

CBB members, George Shaker and Safieddin (Ali) Safavi-Naeini part of team that creates new technology that can quickly and accurately monitor glucose levels in people with diabetes without painful finger pricks to draw blood. 

New technology can quickly and accurately monitor glucose levels in people with diabetes without painful finger pricks to draw blood. 

A palm-sized device developed by researchers at the University of Waterloo uses radar and artificial intelligence (AI) to non-invasively read blood inside the human body.

Researchers at the University of Waterloo are developing a DNA-based vaccine that can be delivered through a nasal spray.

The vaccine will work by using bacteriophage, a process that will allow the vaccine to replicate within bacteria already in the body and is being designed to target tissues in the nasal cavity and lower respiratory tract.

The current COVID-19 pandemic has been putting a strain on healthcare workers around the world. We often forget all the challenges that frontline healthcare professionals have to face, including the use of personal protective equipment. This paper from 2016 describes the evaluation during the ebola crisis, which has excellent recommendations for healthcare workers and managers around the world when dealing with COVID-19.

Researchers at the University of Waterloo have partnered with an artificial intelligence (AI) startup on a project that aims to use AI to improve COVID-19 screening.

The Waterloo research team publicly released AI software that can better detect infections from chest x-rays and is looking to enlist expertise from around the world to aid in the project.